John Oyler sold $10M of ONC
Chief Executive Officer at BeOne Medicines Ltd.. 41,210 shares at an average of $242.67, traded Mar 10, 2025, filed Mar 12, 2025.
Score components
- +25RoleCEO
- +25Trade size$10.0M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001651308-25-000049, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 10, 2025 | MOption exercise Ordinary Shares | +497,822 | $0.50 | $249k | 6,098,625 | Mar 12, 2025 |
| Mar 10, 2025 | MOption exercise American Depositary Shares | +41,210 | $6.50 | $268k | 41,210 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -1,900 | $238.74 | $454k | 39,310 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -6,800 | $239.59 | $1.6M | 32,510 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -2,200 | $240.70 | $530k | 30,310 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -7,069 | $241.92 | $1.7M | 23,241 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -9,309 | $243.04 | $2.3M | 13,932 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -5,313 | $244.04 | $1.3M | 8,619 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -3,006 | $245.19 | $737k | 5,613 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -4,913 | $246.11 | $1.2M | 700 | Mar 12, 2025 |
| Mar 10, 2025 | SOpen-market sale American Depositary Shares | -700 | $246.85 | $173k | 0 | Mar 12, 2025 |
| Mar 10, 2025 | MOption exercise Share Option (Right to Buy)derivative | -1,033,552 | $0.00 | $0 | 4,055,422 | Mar 12, 2025 |
Related signals
Other insiders at BeOne Medicines Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | BeOne Medicines Ltd. | Chan Henry Lee SVP, General Counsel | $418k 1,115 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $11M 31,028 shares | -100% | |
| 33Weak | BeOne Medicines Ltd. | Xiaodong Wang director, other | $13M 38,287 shares | -527% | |
| 49Moderate | BeOne Medicines Ltd. | Titus B. Ball Principal Accounting Officer | $47k 132 shares | -100% | |
| 41Moderate | ONCsell BeOne Medicines Ltd. | Titus B. Ball Principal Accounting Officer | $35k 134 shares | -100% | |
| 40Moderate | BeOne Medicines Ltd. | Xiaodong Wang director, other | $11M 41,760 shares | -100% | |
| 45Moderate | BeOne Medicines Ltd. | Xiaobin Wu President, COO & GM China | $14M 51,921 shares | -100% | |
| 70Notable | BeOne Medicines Ltd. | John Oyler Chief Executive Officer | $10M 40,109 shares | -100% | |
| 70Notable | BeOne Medicines Ltd. | John Oyler Chief Executive Officer | $15M 58,590 shares | -100% | |
| 55Moderate | BeOne Medicines Ltd. | Xiaodong Wang director, other | $2.1M 8,146 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.